171 related articles for article (PubMed ID: 36335744)
1. CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.
Wen J; Wang S; Guo R; Liu D
Eur J Med Chem; 2023 Jan; 245(Pt 1):114884. PubMed ID: 36335744
[TBL] [Abstract][Full Text] [Related]
2. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
[TBL] [Abstract][Full Text] [Related]
3. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
[TBL] [Abstract][Full Text] [Related]
4. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
Cannarile MA; Weisser M; Jacob W; Jegg AM; Ries CH; Rüttinger D
J Immunother Cancer; 2017 Jul; 5(1):53. PubMed ID: 28716061
[TBL] [Abstract][Full Text] [Related]
5. Activity of tumor-associated macrophage depletion by CSF1R blockade is highly dependent on the tumor model and timing of treatment.
O'Brien SA; Orf J; Skrzypczynska KM; Tan H; Kim J; DeVoss J; Belmontes B; Egen JG
Cancer Immunol Immunother; 2021 Aug; 70(8):2401-2410. PubMed ID: 33511454
[TBL] [Abstract][Full Text] [Related]
6. Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy.
Leftin A; Ben-Chetrit N; Joyce JA; Koutcher JA
Sci Rep; 2019 Jan; 9(1):857. PubMed ID: 30696910
[TBL] [Abstract][Full Text] [Related]
7. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
Murga-Zamalloa C; Rolland DCM; Polk A; Wolfe A; Dewar H; Chowdhury P; Onder O; Dewar R; Brown NA; Bailey NG; Inamdar K; Lim MS; Elenitoba-Johnson KSJ; Wilcox RA
Clin Cancer Res; 2020 Feb; 26(3):690-703. PubMed ID: 31636099
[TBL] [Abstract][Full Text] [Related]
8. CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.
Edwards DK; Watanabe-Smith K; Rofelty A; Damnernsawad A; Laderas T; Lamble A; Lind EF; Kaempf A; Mori M; Rosenberg M; d'Almeida A; Long N; Agarwal A; Sweeney DT; Loriaux M; McWeeney SK; Tyner JW
Blood; 2019 Feb; 133(6):588-599. PubMed ID: 30425048
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Pyrrolo[2,3-d]pyrimidine derivatives as potent and selective colony stimulating factor 1 receptor kinase inhibitors.
Liang X; Wang C; Wang B; Liu J; Qi S; Wang A; Liu Q; Deng M; Wang L; Liu J; Liu Q
Eur J Med Chem; 2022 Dec; 243():114782. PubMed ID: 36179404
[TBL] [Abstract][Full Text] [Related]
10. Effects of CSF1R-targeted chimeric antigen receptor-modified NK92MI & T cells on tumor-associated macrophages.
Zhang P; Zhao S; Wu C; Li J; Li Z; Wen C; Hu S; An G; Meng H; Zhang X; Yang L
Immunotherapy; 2018 Aug; 10(11):935-949. PubMed ID: 30149762
[TBL] [Abstract][Full Text] [Related]
11. The c.1085A>G Genetic Variant of
Yeh YM; Hsu SJ; Lin PC; Hsu KF; Wu PY; Su WC; Chang JY; Shen MR
Clin Cancer Res; 2017 Oct; 23(20):6021-6030. PubMed ID: 28724665
[No Abstract] [Full Text] [Related]
12. Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy.
Gyori D; Lim EL; Grant FM; Spensberger D; Roychoudhuri R; Shuttleworth SJ; Okkenhaug K; Stephens LR; Hawkins PT
JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875321
[TBL] [Abstract][Full Text] [Related]
13. Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages.
Zhu M; Bai L; Liu X; Peng S; Xie Y; Bai H; Yu H; Wang X; Yuan P; Ma R; Lin J; Wu L; Huang M; Li Y; Luo Y
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600555
[TBL] [Abstract][Full Text] [Related]
14. Small-Molecule CSF1R Inhibitors as Anticancer Agents.
Xun Q; Wang Z; Hu X; Ding K; Lu X
Curr Med Chem; 2020; 27(23):3944-3966. PubMed ID: 31215373
[TBL] [Abstract][Full Text] [Related]
15. Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor-loaded nanoparticle enhances anticancer efficacy.
Ramesh A; Malik V; Ranjani HA; Smith H; Kulkarni AA
Drug Deliv Transl Res; 2021 Dec; 11(6):2317-2327. PubMed ID: 34365577
[TBL] [Abstract][Full Text] [Related]
16. Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.
Benner B; Good L; Quiroga D; Schultz TE; Kassem M; Carson WE; Cherian MA; Sardesai S; Wesolowski R
Drug Des Devel Ther; 2020; 14():1693-1704. PubMed ID: 32440095
[TBL] [Abstract][Full Text] [Related]
17. Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R.
Liu YQ; Wang YN; Lu XY; Tong LJ; Li Y; Zhang T; Xun QJ; Feng F; Chen YZ; Su Y; Shen YY; Chen Y; Geng MY; Ding K; Li YL; Xie H; Ding J
Acta Pharmacol Sin; 2018 Nov; 39(11):1768-1776. PubMed ID: 29968849
[TBL] [Abstract][Full Text] [Related]
18. Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells.
Santamaria-Barria JA; Zeng S; Greer JB; Beckman MJ; Seifert AM; Cohen NA; Zhang JQ; Crawley MH; Green BL; Loo JK; Maltbaek JH; DeMatteo RP
PLoS One; 2019; 14(5):e0216275. PubMed ID: 31042769
[TBL] [Abstract][Full Text] [Related]
19. Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design.
Machiraju PK; Yedla P; Gubbala SP; Bohari T; Abdul JKV; Xu S; Patel R; Chittireddy VRR; Boppana K; Jagarlapudi SARP; Neamati N; Syed R; Amanchy R
Comput Biol Chem; 2019 Jun; 80():374-383. PubMed ID: 31103918
[TBL] [Abstract][Full Text] [Related]
20. CSF1R- and SHP2-Inhibitor-Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor-Associated Macrophages.
Ramesh A; Kumar S; Nandi D; Kulkarni A
Adv Mater; 2019 Dec; 31(51):e1904364. PubMed ID: 31659802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
